Our data provide an alternative explanation for PD-L1 dysregulation, because the decreased expression of HITT is inversely correlated with PD-L1 expression in breast cancer tissues, and the inhibitory activity of HITT on PD-L1 expression can be demonstrated both in vitro and in orthotopic models. Here, CD274 is linked to breast cancer.